June 11, 2026 · Form 4 insider transaction
Wu Xiaobin bought 229,775 shares of BeOne Medicines AG at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.; These securities vest over a four-year period as follows: 25% on the first anniversary of June 11, 2026 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.